Page last updated: 2024-09-02

quinaprilat and avapro

quinaprilat has been researched along with avapro in 2 studies

Compound Research Comparison

Studies
(quinaprilat)
Trials
(quinaprilat)
Recent Studies (post-2010)
(quinaprilat)
Studies
(avapro)
Trials
(avapro)
Recent Studies (post-2010) (avapro)
922341,369385495

Protein Interaction Comparison

ProteinTaxonomyquinaprilat (IC50)avapro (IC50)
Bile salt export pumpHomo sapiens (human)7.3067
Type-1 angiotensin II receptorHomo sapiens (human)0.0099
Type-2 angiotensin II receptorHomo sapiens (human)0.003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP1

Other Studies

2 other study(ies) available for quinaprilat and avapro

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

2002